METHOD FOR EVALUATING INFLAMMATORY PROCESS ACTIVITY AT PSORIASIS Russian patent published in 2006 - IPC G01N33/68 G01N33/53 

FIELD: medicine.

SUBSTANCE: the present innovation deals with laboratory methods for studying skin diseases by detecting the content of inflammatory process markers in blood serum at the moment of disease exacerbation and in the end of therapy. As markers of inflammatory process one should apply alpha-1 acid glycoprotein and nitrogen oxide. At decreased content of acid glycoprotein in blood serum ranged 1.19-1.21 g/l up to 0.78-0.82, and as for nitrogen oxide ranged 44.5-54.4 mcM/l up to 24-29.2 mcM/l one should evaluate psoriasis activity to be high. At decreased content of alpha-1 acid glycoprotein ranged 1-1.04 g/l - up to 0.76-0.8 g/l, and nitrogen oxide ranged 37.9-43.5 mcM/l up to 20.6-27.4 mcM/l the psoriasis activity should be evaluated as low. The innovation provides higher significance of diagnostics, decreases labor intensity and period for carrying out the experiments mentioned that enables to develop a number of individual curative procedures for every patient.

EFFECT: higher accuracy of evaluation.

2 ex